The hon. Lady is a long-standing and passionate campaigner for Kuvan. The NICE methods review looks at the question she raises. It is important that we have a clinically-led process for approval of medicines, and I know she agrees with that. The methods review will make sure that we take advantage of advances in medical technology which will allow us to bring drugs and treatments to patients more quickly than in the past.

The hon. Lady is a long-standing and passionate campaigner for Kuvan. The NICE methods review looks at the question she raises. It is important that we have a clinically-led process for approval of medicines, and I know she agrees with that. The methods review will make sure that we take advantage of advances in medical technology which will allow us to bring drugs and treatments to patients more quickly than in the past.

We now have a record number of doctors in the NHS. We are on track to meet our manifesto commitment to 50,000 more nurses and have seen an increase in the number of doctors too. Of course there is more to be done but this is undoubtedly a question that we will return to.

Where contracts are not delivered against we do not intend to pay taxpayers' money but also wanted to make sure as much PPE was secured into the country. There were individual instances but no national level shortage, confirmed by the National Audit Office.

What matters for patients is the quality of patient care. Throughout the pandemic, we have seen that what matters most are quality issues. We should look out for that and support staff working hard to deliver on it.

I think my hon. Friend has just made his heartfelt plea and it has certainly landed with me, but I am not surprised because he has made this case to me on behalf of his constituents over and over again and he is quite right to. We are in the process of considering which hospitals will be in the eight additional, on top of the 40 that we committed to in our manifesto. I am grateful for his representations and we will certainly consider Airedale and its full needs for the local community.

We will need to draw many lessons from the pandemic. For instance, my brilliant team who have done all this procurement of PPE have also built an onshore PPE manufacturing capability. With regard to almost all items of PPE, 70% of it is now made onshore in the UK, up from about 2% before the pandemic—likewise for vaccines, where we did not have large-scale vaccine manufacture and we now do, and for a host of other areas, including some of those that the hon. Gentleman mentioned.

My hon. Friend is absolutely right. The court ruling in question found that we were on average 17 days late with the paperwork, but it did not find against any of the individual contracts. My team worked so hard to deliver the PPE that was needed and so, as the National Audit Office has confirmed and as my hon. Friend set out, there was never a point at which there was a national shortage. There were, of course, localised challenges and we were in the situation of a huge increase in global demand, but I think that we should all thank the civil servants who did such a good job.

As we have repeatedly explained, supply is the rate-limiting factor. The hon. Member will no doubt have seen that there have been international discussions on the rate of supply, and countries around the world are finding supply the rate-limiting factor. Thankfully, thanks to the decisions that this Government took early, we have some of the best access to the supply of vaccine in the world. That is why we have one of the best vaccine delivery programmes in the world.

Of course we assess this, but it is challenging to get to a statistical answer to the question that my right hon. Friend raises. When we have taken action to restrict access to areas where there is evidence of significant transmission, such as the hospitality industry, that confounds the statistical analysis because people cannot go into that environment and therefore the passing on of infection there reduces. This is a matter of evidence and judgment. It is a significant challenge, but the road map is based on our best assessment of the situation, which is based on clinical advice, including the focus on the fact that we know that outdoors is safer than indoors. Hence the early steps, after schools, are focused on opening things up outdoors.

Of course long covid is an incredibly serious condition for some and is part of our considerations and deliberations, but I want to correct something the hon. Member said. The road map sets out indicative dates before which we will not move, but we will be guided by the data, hence the five-week gaps between each step to make sure we have four weeks to see the impact of the step and one week of advance notice for the go/no-go decision. That is based on clinical advice, which I know is shared across the UK.

I pay tribute to my hon. Friend's work in making sure that all carers, who are properly in priority group 6, get the opportunity to be vaccinated, including those who may be unregistered with the system, but nevertheless are carers. It is very important and I pay tribute to the work of Norfolk County Council. I know that my hon. Friend the Care Minister will be happy to meet my hon. Friend and the county council to discuss what further can be done.

I am very happy to take up that proposal. Nobody should be harassed when accessing any medical treatment. There are agreed rules around abortion and people should be able to access abortion properly, according to those rules.